Danina Fisher
Director · Hepion Pharmaceuticals, Inc.
IndividualBuying only
- 2026
- Oct 2, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Danina Fisher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Vincent S. Lopriore - $750K in HEPA purchases and sales in the last 12 months
- Michael J. Purcell - $150K in HEPA purchases and sales in the last 12 months
- Sireesh Appajosyula - $150K in HEPA purchases and sales in the last 12 months
- Gary S. Stetz - $150K in HEPA purchases and sales in the last 12 months
- Gary S. Stetz II - $25K in HEPA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Danina Fisher?
Danina Fisher is a corporate insider, tracked as Director of Hepion Pharmaceuticals, Inc. (HEPA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Danina Fisher submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Danina Fisher been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
